InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
5
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-21.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Buchi J Kevin, Director. Insider active across 5 companies, notably Ziopharm Oncology INC. Cumulatively, 19 filings have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €26k. Activity tracked since 4 March 2021. The latest transaction was filed on 11 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Buchi J Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
20,445 股@ US$14.45Class A Common StockSEC:0001628280-26-061836:0
168,573 股@ US$17.180.047% mcap49.8% 占其流量Class A Common StockSEC:0001628280-26-056752:0
51,813 股Common StockSEC:0001193125-26-290586:0
40,258 股Class A Common StockSEC:0001628280-25-024004:0
103,626 股0Common StockSEC:0001062993-25-005393:0
262,072 股0Class A Common StockSEC:0001628280-25-012344:0
51,813 股@ US$3.86100.0% 占其流量Common StockSEC:0001062993-25-004077:0
76,453 股Class A Common StockSEC:0001628280-24-023247:0
51,813 股Common StockSEC:0000950170-23-042536:0
标准退出：2023年11月9日 (T+90)
21,858 股@ US$0.287522.5% 占其流量Common StockSEC:0001615594-23-000047:0
标准退出：2023年9月7日 (T+90)
25,000 股@ US$0.29626.4% 占其流量Common StockSEC:0001615594-23-000046:0
标准退出：2023年9月6日 (T+90)
32,534 股@ US$0.274331.6% 占其流量Common StockSEC:0001615594-23-000033:0
标准退出：2023年8月14日 (T+90)
23,440 股@ US$0.235219.5% 占其流量Common StockSEC:0001615594-23-000032:0
标准退出：2023年8月10日 (T+90)
80,128 股Class A Common StockSEC:0001209191-23-028734:0
35,406 股Class A Common StockSEC:0001209191-22-028155:0
4,666 股@ US$38.25100.0% 占其流量Common StockSEC:0001399529-21-000195:0
4,666 股Common StockSEC:0001399529-21-000106:0
46,218 股Class A Common StockSEC:0001209191-21-030806:0
4,167 股0Common StockSEC:0001209191-21-030738:0
19 条申报中的 19 条
About Buchi J Kevin
BUCHI J KEVIN is a Director of Amneal Pharmaceuticals, Inc., Benitec Biopharma Inc., Ampio Pharmaceuticals, Inc., Dicerna Pharmaceuticals Inc and Ziopharm Oncology INC. He has 17 filings in total. Across the sampled recent filings, his buys total EUR 25956, his sells total EUR 0, the modal transaction nature is Levée d'options, and the date range runs from 2021-05-06 to 2026-06-30.
